Vladimir Subbotin: An Alternative Hypothesis for Coronary Atherosclerosis

In 1987, the American Heart Association claimed cholesterol-lowering statin drugs would

“almost eliminate the necessity for bypass surgery and percutaneous coronary intervention (PCI), and eradicate CA (coronary atherosclerosis) by the end of the 20th century.” Unfortunately, as Vladimir Subbotin, an MD and Ph.D. with expertise in disease pathology, explains, “the prognosis stopped short of satisfying the predictions.” In this presentation, delivered at a CrossFit Health event on Dec. 15, 2019, Subbotin shares his explanation for why statins have failed to meet the AHA’s expectations. That failure, he claims, is due to a fundamentally flawed understanding of the pathogenesis of the disease. He presents an alternative hypothesis.



CrossFit (

crossfit,nutrition,home,at home,movement,functional,exercise,scale,modify,constantly,varied,the mess,messpert,cholesterol,statin,pharma,big pharma,Vladimir Subbotin,Coronary Atherosclerosis Pathogenesis,